Metabolic Brain Disease

, Volume 8, Issue 4, pp 217–234 | Cite as

Astrocytes and the entry of circulating ammonia into the brain: Effect of fluoroacetate

  • John C. Szerb
  • Isabel M. Redondo
Original Contribution

Abstract

Chronic hyperammonemia is known to lead to pathological forms of astrocytes. To test the influence of these changes on the neurotoxicity of ammonia, the glial metabolic poison fluoroacetate (FA) was applied locally, through microdialysis to the hippocampal dentate gyrus. The penetration of ammonia into the brain following the i.p. injection of 7.8 mmol/kg NH4 acetate was evaluated by measuring the ammonia and glutamine content of the microdialysate. Field EPSPs (fEPSPs) evoked by perforant path stimulation were recorded 1.5 mm from the microdialysis probe. When 20 mM FA was perfused, NH4 acetate injection increased the ammonia efflux by 300% and decreased fEPSPs by 40%, but glutamine concentration remained low. With no FA in the microdialysate, NH4 acetate treatment increased the efflux of ammonia by only 60%, did not affect fEPSPs but doubled glutamine efflux. Arterial ammonia content, as measured by microdialysis in the common carotid, increased 4–5 fold following i.p. administration of NH4 acetate, while arterial glutamine was not elevated. Systemically administered FA did not affect either of these changes significantly, but slightly reduced arterial pH. These observations indicate that FA applied by microdialysis acted locally on astrocytes and therefore impaired astrocytic function contributes to the development of hepatic encephalopathy by facilitating the entry of ammonia into the brain. Inhibition of excitatory synaptic transmission by elevated brain ammonia may underlay CNS depression in hepatic encephalopathy.

Key words

Ammonia fluoroacetate microdialysis astrocytes glutamine EPSP 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adams, R.D. and Foley, J.M. (1953). The neurological disorder associated with liver disease. In Merit, H.H. and Hare, C.C. (eds.),Metabolic and Toxic Diseases of the Nervous System, Vol. 32, Williams and Wilkins, Baltimore, pp. 198–237.Google Scholar
  2. Aitken, P.G. (1985). Kainic acid and penicillin: differential effects on excitatory and inhibitory interactions in the CA1 region of the hippocampal slice.Brain Res. 325:261–269.Google Scholar
  3. Armitage, P. and Berry, G. (1987).Statistical Methods in Medical Research, 2nd Ed. Blackwell Scientific Publications, Oxford.Google Scholar
  4. Barnes, C.D. and Etherington, L.G. (1964).Drug Dosage in Laboratory Animals, University of California Press, Berkeley and Los Angeles.Google Scholar
  5. Benitez, D., Pscheidt, G.R. and Stone, W.E. (1954). Formation of ammonium ion in the cerebrum in fluoroacetate poisoning.Am. J. Physiol. 176:488–492.Google Scholar
  6. Benveniste, H. (1989). Brain microdialysis.J. Neurochem. 52:1667–1679.Google Scholar
  7. Benveniste, H., Drejer, J., Schousboe, A. and Diemer, N.H. (1984). Elevation of extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis.J. Neurochem. 43:1369–1374.Google Scholar
  8. Benveniste, H., Hansen, A.J. and Ottosen, N.S. (1989). Determination of brain interstitial concentrations by microdialysis.J. Neurochem. 52:1741–1750.Google Scholar
  9. Butterworth, R.F. (1991). Pathophysiology of hepatic encephalopathy: the ammonia hypothesis revisited. In Bengtsson, F., Jeppson, B., Almdal, T. and Vilstrup, H. (eds.).Hepatic Encephalopathy and Metabolic Nitrogen Exchange, CRC Press, Boca Raton, FL. pp. 9–24.Google Scholar
  10. Butterworth, R.F., Girard, G. and Giguère, J.F. (1988). Regional differences in the capacity for ammonia removal by brain following portacaval anastomosis.J. Neurochem. 51:486–490.Google Scholar
  11. Clarke, D.D., Nicklas, W.J. and Berl, S. (1970). Tricarboxylic acid-cycle metabolism in the brain. Effect of fluoroacetate and fluorocitrate on the labeling of glutamate, aspartate, glutamine and γ-aminobutyrate.Biochem. J. 120:345–351.Google Scholar
  12. Cooper, A.J.L., Mora, S.N., Cruz, N.F. and Gelbard, A.S. (1985). Cerebral ammonia metabolism in hyperammonemic rats.J. Neurochem. 44:1716–1723.Google Scholar
  13. Cooper, A.J.L. and Plum, F. (1987). Biochemistry and physiology of brain ammonia.Physiol. Reviews 67:440–519.Google Scholar
  14. Duffy, T.E. and Plum, F. (1982). Hepatic encephalopathy. In Arias I., Popper, H., Schachter, D. and Shafritz, D.A. (eds),The Liver: Biology and Pathobiology, Raven Press, N.Y. pp. 693–715.Google Scholar
  15. Ehrlich, M., Plum, F. and Duffy, T.E. (1980). Blood and brain ammonia concentrations after portacaval anastomosis. Effects of acute ammonia loading.J. Neurochem. 34:1538–1542.Google Scholar
  16. Fan, P., Lavoie, J., Lé, N.L.O., Szerb, J.C. and Butterworth, R.F. (1990). Neurochemical and electrochemical and electrophysiological studies on the inhibitory effect of ammonium ions on synaptic transmission in slices of rat hippocampus: evidence for a postsynaptic action.Neuroscience 37:327–334.Google Scholar
  17. Gibson, G.E., Zimber, A., Krook, L., Richardson, E.P. Jr. and Visek, W.J. (1974). Brain histology and behavior of mice injected with urease.J. Neuropath. Exp. Neurol. 33:201–211.Google Scholar
  18. Gonda, O. and Quastel, J.H. (1966). Transport and metabolism of acetate in rat cortex in vitro. Biochem. J.100:83–94.Google Scholar
  19. Hassel, B., Paulsen, R.E., Johnsen, A. and Fonnum, F. (1992). Selective inhibition of glial cell metabolismin vivo by fluorocitrate.Brain Res. 576:120–124.Google Scholar
  20. Haussinger, D. (1986). Regulation of hepatic ammonia metabolism: the intracellular glutamine cycle.Adv. Enzyme Regul. 25:159–180.Google Scholar
  21. Hawkins, R.A. and Jessy, J. (1991). Hyperammonaemia does not impair brain function in the absence of net glutamine synthesis.Biochem. J. 277:697–703.Google Scholar
  22. Hawkins, R.A., Jessy, J., Mans, A.M. and De Joseph, M.R. (1993). Effect of reducing brain glutamine synthesis on metabolic symptoms of hepatic encephalopathy.J. Neurochem. 60:1000–1006.Google Scholar
  23. Lavoie, J., Giguère, J.F., Pomier Layrargues, G. and Butterworth, R.F. (1987). Activities of neuronal and astrocytic marker enzymes in autopsied brain tissue from patients with hepatic encephalopathy.Met. Brain Dis. 2:283–290.Google Scholar
  24. Loracher, C. and Lux, H.D. (1974). Impaired hyperpolarising inhibition during insulin hypoglycaemia and fluoroacetate poisoning.Brain Res. 69:164–169.Google Scholar
  25. Miyake, T. and Kitamura, T. (1992). Glutamine synthetase immunoreactivity in two types of mouse brain glial cells.Brain Res. 586:53–60.Google Scholar
  26. Morrison, P.F., Bungay, P.M., Hsiao, J.K., Mefford, I.N., Dykstra, K.H. and Dedrick, R.L. (1991). Quantitative microdialysis. In Robinson, T.E. and Justice, J.B., Jr. (eds.),Microdialysis in Neurosciences, Elsevier, Amsterdam, pp. 47–80.Google Scholar
  27. Muir, D., Berl, S. and Clarke, D.D. (1986). Acetate and fluoroacetate as possible metabolic markers for glial metabolismin vivo.Brain Res. 380:336–340.Google Scholar
  28. Norenberg, M.D., Lapham, L.W., Nichols, F.A. and May, A.G. (1974). An experimental model for the study of hepatic encephalopathy.Archs. Neurol. 31:106–109.Google Scholar
  29. Norenberg, M.D. and Martinez-Hernandez, A. (1979). Fine structural localization of glutamine synthetase in astrocytes in rat brain.Brain Res. 161:303–110.Google Scholar
  30. Paulsen, R.E. and Fonnum, F. (1989). Role of glial cells for the basal and Ca2+-dependent K+-evoked release of transmitter amino acids investigated by microdialysis.J. Neurochem. 52:1823–1829.Google Scholar
  31. Paulsen, R.E., Contestabile, A., Villani, L. and Fonnum, F. (1987). Anin vivo model for studying function of brain tissue temporarily devoid of glial cell metabolism: the use of fiuorocitrate.J. Neurochem. 48:1377–1385.Google Scholar
  32. Paxinos, G. and Watson, C. (1986).The Rat Brain in Stereotaxic Coordinates, 2nd ed., Academic Press, San Diego, CA.Google Scholar
  33. Peters, R.A. (1957). Mechanism of the toxicity of the active constituent ofDichapetalum cymosum and related compounds.Adv. Enzymol. 18:113–159, 1957.Google Scholar
  34. Quastel, J.H. (9174). Metabolic compartmentation in the brain and effect of metabolic inhibitors. In Berl, S., Clarke, D.D. and Schneider, D. (eds.),Metabolic Compartmentation and Neurotransmission, Plenum Press, New York, pp. 337–361.Google Scholar
  35. Raabe, W.A. (1981). Ammonia and disinhibition in cat motor cortex by hypoglycemia.Brain Res. 210:311–322.Google Scholar
  36. Raabe, W. and Onstad, G. (1985). Porta-caval shunting changes neuronal sensitivity to ammonia.J. Neurol. Sci. 71:307–314.Google Scholar
  37. Raichle, M.E. and Larson, K.B. (1981). The significance of the NH3-NH4+ equilibrium on the passage of 13N-ammonia from blood to brain. A new regional residue detection model. Circulation Res.48:913–937.Google Scholar
  38. Saito, T. (1990). Glucose-supported oxidative metabolism and evoked potentials are sensitive to fluoroacetate, an inhibitor of glial carboxylic acid cycle in the olfactory cortex slice.Brain Res. 535:205–213.Google Scholar
  39. SAS Institute Inc.,SAS/STAT User's Guide, Version 6, 4th ed., (1989) Cary, NC.Google Scholar
  40. Szerb, J.C. (1991). Glutamate release and spreading depression in the fascia dentata in response to microdialysis with high K+: role of glia.Brain Res. 542:259–265.Google Scholar
  41. Szerb, J.C. and Butterworth, R.F. (1992). Effect of ammonium ions on synaptic transmission in the mammalian central nervous system.Prog. Neurobiol. 39:135–153.Google Scholar
  42. Szerb, J.C. and Issekutz, B. (1987). Increase in the stimulation-induced overflow of glutamate by fluoroacetate, a selective inhibitor of the glial tricarboxylic cycle.Brain Res. 410:116–120.Google Scholar
  43. Tansey, F.A. Farooq, M. and Cammer, W. (1991). Glutamine synthetase in oligodendrocytes and astrocytes: new biochemical and immunochemical evidence.J. Neurochem. 56:266–272.Google Scholar
  44. Théoret, Y. and Bossu, J.L. (1985). Effects of ammonium salts on synaptic transmission to hippocampal CA1 and CA3 pyramidal cellsin vivo. Neuroscience14:807–821.Google Scholar
  45. Théoret, Y., Davies, M.F., Esplin, B. and Capek, R. (1985). Effects of ammonium chloride on synaptic transmission in the rat hippocampal slice.Neuroscience 14:798–806.Google Scholar
  46. Zieve, L. (1982). Hepatic encephalopathy. In Schiff, L. and Schiff, E.R. (eds.),Diseases of the Liver, Lippincott, Philadelphia, pp. 433–459.Google Scholar
  47. Zieve, L. Lyftogt, C. and Draves, K. (1983). Toxicity of fatty acid and ammonia: interaction with hypoglycemia and Krebs cyle inhibition.J. Lab. Clin. Med. 101:930–939.Google Scholar

Copyright information

© Plenum Publishing Corporation 1993

Authors and Affiliations

  • John C. Szerb
    • 1
  • Isabel M. Redondo
    • 1
  1. 1.Department of Physiology and Biophysics and Institute of NeuroscienceDalhousie UniversityHalifaxCanada

Personalised recommendations